{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T16:25:33Z","timestamp":1790526333999,"version":"4.1.0"},"reference-count":49,"publisher":"Impact Journals, LLC","issue":"25","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,6,21]]},"DOI":"10.18632\/oncotarget.9500","type":"journal-article","created":{"date-parts":[[2016,5,21]],"date-time":"2016-05-21T06:36:12Z","timestamp":1463812572000},"page":"38180-38190","source":"Crossref","is-referenced-by-count":131,"title":["Genetic heterogeneity in primary and relapsed mantle cell lymphomas: Impact of recurrent\n                    <i>CARD11<\/i>\n                    mutations"],"prefix":"10.18632","volume":"7","author":[{"given":"Chenglin","family":"Wu","sequence":"first","affiliation":[{"name":"Division of Clinical Immunology and Transfusion Medicine, Karolinska Institutet at Karolinska University Hospital, Huddinge, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel FCC","family":"de Miranda","sequence":"additional","affiliation":[{"name":"Division of Clinical Immunology and Transfusion Medicine, Karolinska Institutet at Karolinska University Hospital, Huddinge, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longyun","family":"Chen","sequence":"additional","affiliation":[{"name":"Division of Clinical Immunology and Transfusion Medicine, Karolinska Institutet at Karolinska University Hospital, Huddinge, Sweden"},{"name":"Beijing Genomics Institute, Shenzhen, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agata M.","family":"Wasik","sequence":"additional","affiliation":[{"name":"Division of Pathology, Department of Laboratory Medicine, Karolinska Institutet at Karolinska University Hospital, Huddinge, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry","family":"Mansouri","sequence":"additional","affiliation":[{"name":"Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Jurczak","sequence":"additional","affiliation":[{"name":"Department of Hematology, Jagiellonian University Collegium Medicum, Krak\u00f3w, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystyna","family":"Galazka","sequence":"additional","affiliation":[{"name":"Department of Pathology, Jagiellonian University Collegium Medicum, Krak\u00f3w, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Dlugosz-Danecka","sequence":"additional","affiliation":[{"name":"Department of Hematology, Jagiellonian University Collegium Medicum, Krak\u00f3w, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Machaczka","sequence":"additional","affiliation":[{"name":"Faculty of Health Sciences, Jagiellonian University Collegium Medicum, Michalowskiego, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huilai","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Lymphoma, Tianjin Medical University Cancer Hospital and Institute, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roujun","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan D.","family":"Morin","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Rosenquist","sequence":"additional","affiliation":[{"name":"Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgitta","family":"Sander","sequence":"additional","affiliation":[{"name":"Division of Pathology, Department of Laboratory Medicine, Karolinska Institutet at Karolinska University Hospital, Huddinge, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Pan-Hammarstr\u00f6m","sequence":"additional","affiliation":[{"name":"Division of Clinical Immunology and Transfusion Medicine, Karolinska Institutet at Karolinska University Hospital, Huddinge, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,5,20]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1182\/blood-2002-11-3479","article-title":"Mutated VH genes and preferential VH3-21 use define new subsets of mantle cell lymphoma","volume":"101","author":"Enblad","year":"2003","journal-title":"Blood"},{"key":"2","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1182\/blood-2003-05-1383","article-title":"VH mutation status and VDJ rearrangement structure in mantle cell lymphoma: correlation with genomic aberrations, clinical characteristics, and outcome","volume":"102","author":"Dohner","year":"2003","journal-title":"Blood"},{"key":"3","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1182\/blood-2011-03-343434","article-title":"Is there a role for antigen selection in mantle cell lymphoma? Immunogenetic support from a series of 807 cases","volume":"118","author":"Anagnostopoulos","year":"2011","journal-title":"Blood"},{"key":"4","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1016\/j.ajpath.2015.02.006","article-title":"Molecular Evidence for Antigen Drive in the Natural History of Mantle Cell Lymphoma","volume":"185","author":"Ponzoni","year":"2015","journal-title":"Am J Pathol"},{"key":"5","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1172\/JCI61272","article-title":"Molecular pathogenesis of mantle cell lymphoma","volume":"122","author":"Campo","year":"2012","journal-title":"J Clin Invest"},{"key":"6","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/ajh.23615","article-title":"Mantle cell lymphoma: 2013 Update on diagnosis, risk-stratification, and clinical management","volume":"88","author":"Vose","year":"2013","journal-title":"Am J Hematol"},{"key":"7","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1182\/blood-2010-04-189977","article-title":"Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era","volume":"117","author":"Wiestner","year":"2011","journal-title":"Blood"},{"key":"8","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1182\/blood.V99.1.238","article-title":"ATM gene inactivation in mantle cell lymphoma mainly occurs by truncating mutations and missense mutations involving the phosphatidylinositol-3 kinase domain and is associated with increasing numbers of chromosomal imbalances","volume":"99","author":"Campo","year":"2002","journal-title":"Blood"},{"key":"9","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.1182\/blood.V87.10.4302.bloodjournal87104302","article-title":"p53 mutations in mantle cell lymphoma are associated with variant cytology and predict a poor prognosis","volume":"87","author":"Weisenburger","year":"1996","journal-title":"Blood"},{"key":"10","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1038\/leu.2011.162","article-title":"Impact of TP53 mutation and 17p deletion in mantle cell lymphoma","volume":"25","author":"Rosenquist","year":"2011","journal-title":"Leukemia"},{"key":"11","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1182\/blood-2008-12-194852","article-title":"TNFAIP3\/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas","volume":"114","author":"Seto","year":"2009","journal-title":"Blood"},{"key":"12","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10351","article-title":"Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma","volume":"476","author":"Scott","year":"2011","journal-title":"Nature"},{"key":"13","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1073\/pnas.1121343109","article-title":"Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing","volume":"109","author":"Ansell","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"14","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nature09730","article-title":"Inactivating mutations of acetyltransferase genes in B-cell lymphoma","volume":"471","author":"Murty","year":"2011","journal-title":"Nature"},{"key":"15","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1182\/blood-2013-12-546309","article-title":"Exome sequencing reveals novel mutation targets in diffuse large B-cell lymphomas derived from Chinese patients","volume":"124","author":"Pan-Hammarstrom","year":"2014","journal-title":"Blood"},{"key":"16","article-title":"Genetic basis of PD-L1 overexpression in diffuse large B-cell lymphomas","author":"Meng","year":"2016","journal-title":"Blood"},{"key":"17","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1158\/1078-0432.CCR-15-2123","article-title":"Genetic Landscapes of Relapsed and Refractory Diffuse Large B-Cell Lymphomas","volume":"22","author":"Crump","year":"2016","journal-title":"Clin Cancer Res"},{"key":"18","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/ng.2856","article-title":"Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma","volume":"46","author":"Marzec","year":"2014","journal-title":"Nat Genet"},{"key":"19","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/ng.2469","article-title":"Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing","volume":"44","author":"Paulsen","year":"2012","journal-title":"Nat Genet"},{"key":"20","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1182\/blood-2011-11-391474","article-title":"Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma","volume":"119","author":"Opat","year":"2012","journal-title":"Blood"},{"key":"21","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1182\/blood-2013-01-478834","article-title":"The E3 ubiquitin ligase UBR5 is recurrently mutated in mantle cell lymphoma","volume":"121","author":"Gascoyne","year":"2013","journal-title":"Blood"},{"key":"22","doi-asserted-by":"crossref","first-page":"18250","DOI":"10.1073\/pnas.1314608110","article-title":"Landscape of somatic mutations and clonal evolution in mantle cell lymphoma","volume":"110","author":"Clot","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"23","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1182\/blood-2013-07-517177","article-title":"The genomic landscape of mantle cell lymphoma is related to the epigenetically determined chromatin state of normal B cells","volume":"123","author":"Scotland","year":"2014","journal-title":"Blood"},{"key":"24","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1073\/pnas.1205299110","article-title":"Genetic heterogeneity of diffuse large B-cell lymphoma","volume":"110","author":"Lagoo","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"25","doi-asserted-by":"crossref","first-page":"13615","DOI":"10.1073\/pnas.1518646112","article-title":"The human gene damage index as a gene-level approach to prioritizing exome variants","volume":"112","author":"Kong","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"26","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/modpathol.2009.194","article-title":"Expression of sphingosine-1-phosphate receptor 1 in mantle cell lymphoma","volume":"23","author":"Sadahira","year":"2010","journal-title":"Mod Pathol"},{"key":"27","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/labinvest.2013.7","article-title":"Sphingosine-1-phosphate receptor 1 in classical Hodgkin lymphoma: assessment of expression and role in cell migration","volume":"93","author":"Sanchez","year":"2013","journal-title":"Lab Invest"},{"key":"28","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1126\/science.1153629","article-title":"Oncogenic CARD11 mutations in human diffuse large B cell lymphoma","volume":"319","author":"Gascoyne","year":"2008","journal-title":"Science"},{"key":"29","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1084\/jem.20120904","article-title":"The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development","volume":"209","author":"Cresta","year":"2012","journal-title":"J Exp Med"},{"key":"30","doi-asserted-by":"crossref","first-page":"a000109","DOI":"10.1101\/cshperspect.a000109","article-title":"Oncogenic activation of NF-kappaB","volume":"2","author":"Staudt","year":"2010","journal-title":"Cold Spring Harbor perspectives in biology"},{"key":"31","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nm.3435","article-title":"Pharmacological and genomic profiling identifies NF-kappaB-targeted treatment strategies for mantle cell lymphoma","volume":"20","author":"Rakiec","year":"2014","journal-title":"Nat Med"},{"key":"32","doi-asserted-by":"crossref","first-page":"W77","DOI":"10.1093\/nar\/gkt439","article-title":"WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013","volume":"41","author":"Zhang","year":"2013","journal-title":"Nucleic acids Res"},{"key":"33","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: Kyoto Encyclopedia of Genes and Genomes","volume":"28","author":"Goto","year":"2000","journal-title":"Nucleic acids Res"},{"key":"34","doi-asserted-by":"crossref","first-page":"5307","DOI":"10.1158\/0008-5472.CAN-12-1615","article-title":"Molecular Subsets of Mantle Cell Lymphoma Defined by the IGHV Mutational Status and SOX11 Expression Have Distinct Biologic and Clinical Features","volume":"72","author":"Palomero","year":"2012","journal-title":"Cancer Res"},{"key":"35","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1056\/NEJMra1204892","article-title":"The implications of clonal genome evolution for cancer medicine","volume":"368","author":"Caldas","year":"2013","journal-title":"N Engl J Med"},{"key":"36","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/nri1352","article-title":"CARMA1, BCL-10 and MALT1 in lymphocyte development and activation","volume":"4","author":"Thome","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"37","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S1470-2045(14)70311-0","article-title":"Combination of ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for treatment-naive patients with CD20-positive B-cell non-Hodgkin lymphoma: a non-randomised, phase 1b study","volume":"15","author":"Hellemans","year":"2014","journal-title":"Lancet Oncol"},{"key":"38","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ccr.2012.05.024","article-title":"Exploiting synthetic lethality for the therapy of ABC diffuse large B cell lymphoma","volume":"21","author":"Zhao","year":"2012","journal-title":"Cancer cell"},{"key":"39","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Durbin","year":"2009","journal-title":"Bioinformatics"},{"key":"40","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1101\/gr.129684.111","article-title":"VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing","volume":"22","author":"Wilson","year":"2012","journal-title":"Genome Res"},{"key":"41","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1101\/gr.107524.110","article-title":"The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data","volume":"20","author":"DePristo","year":"2010","journal-title":"Genome Res"},{"key":"42","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1093\/bioinformatics\/btr330","article-title":"The variant call format and VCFtools","volume":"27","author":"Genomes Project Analysis","year":"2011","journal-title":"Bioinformatics"},{"key":"43","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/bib\/bbs017","article-title":"Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration","volume":"14","author":"Mesirov","year":"2013","journal-title":"Brief Bioinform"},{"key":"44","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1093\/bioinformatics\/btr462","article-title":"Exome sequencing-based copy-number variation and loss of heterozygosity detection: ExomeCNV","volume":"27","author":"Nelson","year":"2011","journal-title":"Bioinformatics"},{"key":"45","doi-asserted-by":"crossref","first-page":"R41","DOI":"10.1186\/gb-2011-12-4-r41","article-title":"GISTIC2. 0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers","volume":"12","author":"Getz","year":"2011","journal-title":"Genome Biol"},{"key":"46","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/1471-2105-13-134","article-title":"Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction","volume":"13","author":"Madden","year":"2012","journal-title":"BMC bioinformatics"},{"key":"47","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/nprot.2007.135","article-title":"A protocol for rapid generation of recombinant adenoviruses using the AdEasy system","volume":"2","author":"He","year":"2007","journal-title":"Nat Protoc"},{"key":"48","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1182\/blood-2010-03-275859","article-title":"High-throughput immunoglobulin repertoire analysis distinguishes between human IgM memory and switched memory B-cell populations","volume":"116","author":"Dunn-Walters","year":"2010","journal-title":"Blood"},{"key":"49","doi-asserted-by":"crossref","first-page":"D1006","DOI":"10.1093\/nar\/gkn838","article-title":"IMGT, the international ImMunoGeneTics information system","volume":"37","author":"Lefranc","year":"2009","journal-title":"Nucleic acids Res"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.9500","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T09:11:07Z","timestamp":1589274667000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.9500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,20]]},"references-count":49,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2016,6,21]]}},"alternative-id":["9500","27224912"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.9500","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,20]]}}}